Showing results (201-210 of 360) with videos related to
Sort By:
Pageof 36
Cancers|September 28, 2021
Adherence to Treatment Guidelines and Associated Survival in Older Patients with Prostate Cancer: A Prospective Multicentre Cohort StudyAdolfo González Serrano, Claudia Martínez Tapia, Alexandre de la Taille, et al.Molecular Cancer|April 28, 2010
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cellsMengqian Chen, Michael A Feuerstein, Elina Levina, et al.The Prostate|April 26, 2006
Protocadherin-PC promotes androgen-independent prostate cancer cell growthStephane Terry, Luis Queires, Sixtina Gil-Diez-de-Medina, et al.Clinical Genitourinary Cancer|August 25, 2016
Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary CohortDamien Pouessel, Sylvie Bastuji-Garin, Nadine Houédé, et al.Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
A Standardized Method for Estimating the Carbon Footprint of Disposable Minimally Invasive Surgical Devices: Application in Transurethral Prostate SurgeryVincent Misrai, Enrique Rijo, Jean-Baptiste Cottenceau, et al.European Urology|October 7, 2015
Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot StudyRené Yiou, Leila Hamidou, Brigitte Birebent, et al.World Journal of Urology|February 1, 2018
Prostatic injection of botulinum toxin is not inferior to optimized medical therapy in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a randomized clinical trialGrégoire Robert, Aurélien Descazeaud, Gilles Karsenty, et al.European Urology|December 16, 2010
Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillanceGuillaume Ploussard, Xavier Durand, Evanguelos Xylinas, et al.World Journal of Urology|February 13, 2021
Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic reviewGaëtan Devos, Bram Vansevenant, Gert De Meerleer, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 23, 2018
Reappraisal of HER2 status in the spectrum of advanced urothelial carcinoma: a need of guidelines for treatment eligibilityAnissa Moktefi, Damien Pouessel, Jing Liu, et al.Pageof 36